Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids

Area of Science:

• Ophthalmology
• Genetics
• Immunology

Background:

• Mitochondrial DNA (mtDNA) variations and complement pathway abnormalities are linked to age-related macular degeneration (AMD) pathogenesis.
• Understanding the specific role of mtDNA in AMD is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the impact of mtDNA from AMD patients on the complement pathway.
• To elucidate the role of mitochondrial dysfunction in AMD.

Main Methods:

• Transmitochondrial cybrids were created by fusing AMD and normal subject platelets with mtDNA-deficient ARPE-19 cells.
• Quantitative PCR and Western blotting analyzed complement marker gene and protein expression.
• Seahorse XF24 flux analyzer assessed bioenergetic profiles of cybrids.

Main Results:

• AMD cybrids showed decreased complement inhibitor expression and increased complement activator levels compared to normal cybrids.
• Bioenergetic profiles of older normal and AMD cybrids were similar but lower than young normal cybrids.
• These findings implicate mtDNA variations in complement dysregulation in AMD.

Conclusions:

• Observed complement pathway changes in cybrids are attributable to AMD subject mtDNA, highlighting the mitochondrial genome's role.
• Retrograde signaling, not respiratory pathways, may mediate mitochondrial-nuclear communication in AMD.
• mtDNA variations are a significant factor in AMD pathogenesis, influencing complement system activity.